Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
23.23
-0.36 (-1.53%)
At close: Jan 22, 2025, 4:00 PM
23.41
+0.18 (0.77%)
After-hours: Jan 22, 2025, 5:32 PM EST
Immunovant Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$46.11
Upside
+98.49%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $48 → $45 | Strong Buy | Maintains | $48 → $45 | +93.72% | Jan 15, 2025 |
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $47 → $45 | Buy | Maintains | $47 → $45 | +93.72% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +119.54% | Nov 8, 2024 |
| Raymond James | Raymond James | Buy Initiates $36 | Buy | Initiates | $36 | +54.97% | Oct 10, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $47 → $53 | Buy | Maintains | $47 → $53 | +128.15% | Oct 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +119.54% | Sep 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +119.54% | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
| UBS | UBS | Strong Buy Maintains $42 → $41 | Strong Buy | Maintains | $42 → $41 | +76.50% | Aug 13, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $51 → $46 | Buy | Maintains | $51 → $46 | +98.02% | Aug 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $50 → $46 | Buy | Maintains | $50 → $46 | +98.02% | Jun 3, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.